Exploring Physiological Responses of Virtual Reality Walking Exercise Versus Treadmill Walking in Healthy Individuals
Comparison of Physiological Responses of Virtual Reality Walking Exercise Compared to Walking Performed on Treadmills in Healthy Individuals
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study was designed as a single-blind, randomized controlled trial. It was conducted in accordance with the Declaration of Helsinki, adhering to ethical principles for medical research involving human participants. Faculty of health sciences students from İstanbul Atlas University were invited to participate in this study. The inclusion criteria were as follows: aged between 18 and 25 years; classified as inactive or minimally active according to the International Physical Activity Questionnaire score; voluntary consent to participate; and a body mass index (BMI) of ≤30 kg/m².
Participants were excluded from the study if they met any of the following conditions: presence of visual, auditory, vestibular, or neurological deficits; a history of inflammatory diseases, surgeries, or cancer; any cardiopulmonary disorders, including asthma, within the last six months; major musculoskeletal injuries sustained within the last six months; other health issues that could compromise safety during exercise; or conditions known to affect autonomic nervous system (ANS) function, such as diabetes mellitus or autonomic neuropathy or current smoking status or failure to adhere to the experimental procedures of our study.
Our study comprehensively examines the effects of virtual reality (VR) walking exercise and traditional treadmill walking on autonomic nervous system (ANS) and fatigue levels during recovery.
Investigations into the physiological responses elicited by VR exercise interventions underscore a critical gap in our understanding of how VR modalities produce distinct responses compared with conventional exercise forms, particularly treadmill walking.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kagıthane
-
Istanbul, Kagıthane, Turkey, 34413
- Istanbul Atlas University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- classified as inactive or minimally active according to the International Physical Activity Questionnaire score
- voluntary consent to participate
- body mass index (BMI) of ≤30 kg/m²
Exclusion Criteria:
- presence of visual, auditory, vestibular, or neurological deficits
- a history of inflammatory diseases, surgeries, or cancer
- any cardiopulmonary disorders, including asthma, within the last six months
- major musculoskeletal injuries sustained within the last six months
- function, such as diabetes mellitus or autonomic neuropathy
- current smoking status
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Reality Walking Exercise
Walking in virtual reality combined with treadmill exercise
|
Walking on the treadmill with the Free Run game on the Nintendo Wii allows users to walk at 5 miles per hour for 20 minutes.
The user gets on the Wii Balance Board and starts walking in the virtual environment after running the application.
The application detects the user's movements and controls the progress of the virtual character.
During this experience, users increase their motivation by encountering various landscapes while tracking their performance and getting information about the calories they spend.
This setup provides a fun, game-like atmosphere for a realistic walking experience.
|
|
Experimental: Walking on Treadmill
walking on treadmills
|
The study included two intervention groups, consisting of participants who met the inclusion criteria and adhered to the experimental procedures.
One group will do treadmill walking exercises, while the other will do treadmill walking exercises using virtual reality (VR).
Both interventions were conducted in a single session, with each group participating in a 20-minute walking exercise session at a moderate intensity, as identified by other studies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
autonomic nervous system and fatigue levels
Time Frame: Assessments were conducted at four key time points: before the exercise session (T1), immediately after exercise completion (T2), and during the recovery phase at ten minutes post-exercise (T3) and thirty minutes post-exercise (T4).
|
Measure: OMNI Scale of Perceived Exertion (OMNI). Unit of Measure: OMNI Scale ranges from 0 (no fatigue) to 10 (maximum fatigue). Interpretation: Higher scores indicate greater perceived exertion and fatigue, while lower scores suggest less perceived exertion. |
Assessments were conducted at four key time points: before the exercise session (T1), immediately after exercise completion (T2), and during the recovery phase at ten minutes post-exercise (T3) and thirty minutes post-exercise (T4).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Autonomous Nervous System
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.